Allbirds, Inc. — BIRD
| Close Price | Market Cap | P/E Ratio | Forward P/E Ratio | Implied Growth* | Implied Forward Growth* | Dividend | P/B Ratio |
|---|---|---|---|---|---|---|---|
| $4.09 | $33.59M | - | -0.5 | N/A | - | - | 0.6 |
Latest Headlines
- · Bet on These 5 Top-Ranked Stocks With Rising P/E
- · Biologica Launches with Science-Backed Women's Health Essentials Designed for Every Hormonal Stage
- · Macy's Ups FY25 View After Posting Q3 Earnings Beat & Y/Y Comps Growth
- · Nike, Syre Ink Multi-Year Agreement for Textile-to-Textile Recycled Polyester
- · Allbirds leans on new product launches to stoke turnaround
- · Allbirds Inc (BIRD) Q3 2025 Earnings Call Highlights: Navigating Challenges with New Products ...
Revenue & Net Income
| Date | Revenue | Net Income | EPS | Revenue Change | Net Income Change | EPS Change | |
|---|---|---|---|---|---|---|---|
| 0 | 2020-12-31 | $219.3M | $-25.9M | $-0.20 | N/A | N/A | N/A |
| 1 | 2021-12-31 | $277.5M | $-45.4M | $-0.65 | 26.5% | 75.4% | 219.2% |
| 2 | 2022-12-31 | $297.8M | $-101.4M | $-0.68 | 7.3% | 123.4% | 4.6% |
| 3 | 2023-12-31 | $254.1M | $-152.5M | $-1.01 | -14.7% | 50.4% | 48.5% |
| 4 | 2024-12-31 | $189.8M | $-93.3M | $-11.87 | -25.3% | -38.8% | 1075.2% |
| 5 | TTM 2025-03-31 | $182.5M | $-87.9M | $-11.08 | -3.8% | -5.8% | -6.7% |
| 6 | Average | -2.0% | 40.9% | 268.2% |
EPS
Forecasts
Y/Y % Change
BIRD Year-over-Year Growth
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Average | |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth (%) | 26.5% | 7.3% | -14.7% | -25.3% | -15.0% | 0.9% | -3.4% | |
| Revenue Analysts (#) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| EPS Growth (%) | 75.4% | 123.4% | 50.4% | -38.8% | -17.6% | -8.4% | 30.7% | |
| EPS Analysts (#) | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Expenses
| Year | Revenue ($) | Cost of Revenue ($) | Sales & Marketing ($) | G&A ($) | SG&A ($) | Facilities / D&A ($) |
|---|---|---|---|---|---|---|
| 2021 | $277.5M | $121.2M | $57.3M | $122.2M | $179.5M | $9.7M |
| 2022 | $297.8M | $153.5M | $59.1M | $166.7M | $225.8M | $14.7M |
| 2023 | $254.1M | $128.8M | $49.0M | $174.0M | $223.1M | $21.0M |
| 2024 | $189.8M | $96.3M | $41.6M | $133.4M | $175.0M | $12.4M |
| TTM | $160.6M | $90.5M | $44.5M | $100.2M | $144.7M | $7.9M |
| Year | Revenue Change (%) | Cost of Revenue Change (%) | Sales & Marketing Change (%) | G&A Change (%) | SG&A Change (%) | Facilities / D&A Change (%) |
|---|---|---|---|---|---|---|
| 2022 | 7.31 | 26.66 | 3.09 | 36.45 | 25.79 | 52.07 |
| 2023 | -14.68 | -16.05 | -17.03 | 4.38 | -1.22 | 43.10 |
| 2024 | -25.31 | -25.25 | -15.10 | -23.36 | -21.55 | -40.99 |
| TTM | -15.34 | -6.04 | 6.98 | -24.88 | -17.30 | -36.37 |
No unmapped expenses.
Balance Sheet
| Metric | Value | |
|---|---|---|
| 0 | Total Assets | $137M |
| 1 | Cash | $33M |
| 2 | Total Liabilities | $65M |
| 3 | Total Debt | $38M |
| 4 | Total Equity | $71M |
| 5 | Debt to Equity Ratio | 0.53 |
EPS & Dividend
Valuation
| Share Price | Treasury Yield | Estimates | Fair Value (P/E) | Fair Value (P/S) | Current P/S | Current P/E |
|---|---|---|---|---|---|---|
| $4.09 | 4.1% | Nicks Growth: 8% Nick's Expected Margin: 5% FINVIZ Growth: 27% |
Nicks: 15 Finviz: 79 |
Nick's: 0.730 | 0.2 | - |
| Basis | Year | Nicks Valuation | Nicks vs Share Price | Finviz Valuation | Finviz vs Share Price |
|---|---|---|---|---|---|
| $19.56 Revenue | TTM | $14.28 | 249.2% | $76.88 | 1779.8% |
| $19.63 Revenue | 2025 | $14.33 | 250.4% | $77.15 | 1786.4% |
| $19.80 Revenue | 2026 | $14.46 | 253.5% | $77.82 | 1802.7% |
Implied Growth
No implied growth data available.